ClinicalTrials.gov
public full text
Public Domain
Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes
This is a prospective, multicenter phase II trial designed to evaluate the safety and activity of the combination of association of arsenic trioxide (ATO) and ascorbic acid in patients with myelodysplastic syndromes
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Mutant p53-based Personalized Trial Using Decitabine and Arsenic Trioxide on AML/MDS#804196
- A Study to Evaluate BBI-001 in Healthy Volunteers and in Patients With Hereditary Hemochromatosis#1093975
- Study of MRI Monitoring in Patients With Aplastic Anemia and Low or Int-1 Risk of MDS Complicated With Iron Overload#806805
- Safety of SP-420 in the Treatment of Transfusional Iron Overload#1152020
- Effect of Intravenously Iron Infusion on the Prevention and Treatment of Anemia in Ovarian Cancer#889982
Record · ID 869071
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive